These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 13559900)

  • 1. The significance of human antiviral neutralizing substances in animal sera.
    KLEIN M
    Ann N Y Acad Sci; 1958 Jun; 70(3):362-8. PubMed ID: 13559900
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation between canine distemper and measles virus neutralizing capacities in human sera.
    CARLSTROM G
    Arch Gesamte Virusforsch; 1959; 8(5):539-48. PubMed ID: 13650526
    [No Abstract]   [Full Text] [Related]  

  • 3. Neutralizing antibodies against some neurotropic viruses determined in human sera in Albania.
    BARDOS V; ADAMCOVA J; DEDEI S; GJINI N; ROSICKY B; SIMKOVA A
    J Hyg Epidemiol Microbiol Immunol; 1959; 3():277-82. PubMed ID: 13796704
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunological study of antibodies neutralizing Tahyna virus in the sera of inhabitants of Czechoslovakia.
    BARDOS V
    J Hyg Epidemiol Microbiol Immunol; 1960; 4():54-60. PubMed ID: 13796708
    [No Abstract]   [Full Text] [Related]  

  • 5. Investigation of the specificity of substances in some human sera which are inhibitory in certain viral and rickettsial complement-fixing antigen-antibody systems.
    SCHMIDT NJ; HARDING HB
    J Bacteriol; 1956 Feb; 71(2):223-8. PubMed ID: 13295198
    [No Abstract]   [Full Text] [Related]  

  • 6. [Specific and nonspecific factors in antiviral immunity].
    KOSIAKOV PN
    Vestn Akad Med Nauk SSSR; 1962; 17(5)():13-24. PubMed ID: 14458634
    [No Abstract]   [Full Text] [Related]  

  • 7. [On substances in domestic animals neutralizing various human entero-viruses and their possible significance for the ecology of these viruses].
    MITTELSTRASS HK; SAUTHOFF R
    Monatsschr Kinderheilkd (1902); 1961 Mar; 109():202-4. PubMed ID: 13771438
    [No Abstract]   [Full Text] [Related]  

  • 8. Neutralizing antibodies for certain viruses in the sera of human beings residing in Northern Natal.
    SMITHBURN KC; KOKERNOT RH; HEYMANN CS; WEINBREN MP; ZENTKOWSKY D
    S Afr Med J; 1959 Jul; 33(27):555-61. PubMed ID: 13675877
    [No Abstract]   [Full Text] [Related]  

  • 9. Poliovirus neutralizing properties of equine and other sera.
    PLUMMER G
    Nature; 1963 Mar; 197():870-2. PubMed ID: 13944112
    [No Abstract]   [Full Text] [Related]  

  • 10. Neutralizing antibodies against certain viruses in the sera of residents of Trinidad, B.W.I.
    ANDERSON CR; DOWNS WG; THEILER M
    Am J Trop Med Hyg; 1956 Jul; 5(4):626-41. PubMed ID: 13354884
    [No Abstract]   [Full Text] [Related]  

  • 11. The biological significance of the interferon system.
    Baron S
    Arch Intern Med; 1970 Jul; 126(1):84-93. PubMed ID: 5425519
    [No Abstract]   [Full Text] [Related]  

  • 12. An antiviral substance from Penicillium funiculosum. VI. Prevention of the establishment of passive immunity to Semliki Forest virus infection in mice by Helenine.
    Shope RE
    J Exp Med; 1966 Jul; 124(1):15-31. PubMed ID: 5944346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel antiviral therapy based on innate immunity.
    Rico T; Green J; Kirsner RS
    J Invest Dermatol; 2009 Nov; 129(11):2540. PubMed ID: 19826443
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiviral agents.
    Friedman RM
    Md State Med J; 1971 Apr; 20(4):70-5. PubMed ID: 5575816
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunization in virus disease.
    Tan DS
    Med J Malaya; 1965 Sep; 20(1):19-28. PubMed ID: 4221407
    [No Abstract]   [Full Text] [Related]  

  • 16. ESF-EMBO symposium: antiviral applications of RNA interference.
    ter Brake O; Haasnoot J; Kurreck J; Berkhout B
    Retrovirology; 2008 Sep; 5():81. PubMed ID: 18801178
    [No Abstract]   [Full Text] [Related]  

  • 17. Natural antibodies to IFN-gamma in man and their increase during viral infection.
    Caruso A; Bonfanti C; Colombrita D; De Francesco M; De Rango C; Foresti I; Gargiulo F; Gonzales R; Gribaudo G; Landolfo S
    J Immunol; 1990 Jan; 144(2):685-90. PubMed ID: 1688583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral therapy.
    Stalder H
    Yale J Biol Med; 1977; 50(5):507-32. PubMed ID: 341538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A direct quantitative PCR-based measurement of herpes simplex virus susceptibility to antiviral drugs and neutralizing antibodies.
    Virók DP; Eszik I; Mosolygó T; Önder K; Endrész V; Burián K
    J Virol Methods; 2017 Apr; 242():46-52. PubMed ID: 28093274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches to antiviral chemotherapy for acute respiratory infections.
    Shigeta S
    Antivir Chem Chemother; 1998 Mar; 9(2):93-107. PubMed ID: 9875381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.